This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with PeripheralArteryDisease (PAD) who were unable or unwilling to take statin medications. Bonaca, MD, MPH, FAHA, FACC, CPC Clinical Research. tim.hodson Tue, 12/03/2024 - 16:52 Nov.
Study end points include mortality, cardiovascular events (hospitalization for acute myocardial infarction or stroke) and limb events (hospitalization for critical limb ischemia or major amputation) and were identified using Veterans Affairs and nonVeterans Affairs encounters.ResultsThe mean age was 70.6 were male, and 18.5%
New study findings underscore gaps in clinical trial representation of women and Hispanics for peripheralarterydisease (PAD) and chronic limb-threatening ischemia (CLTI) research. All studies were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
Chronic Limb-Threatening Ischemia (CLTI) represents the most advanced stage of PeripheralArteryDisease (PAD) and is associated with dire prognosis, characterized by a substantial risk of limb amputation and.
A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheralarterydisease surgeries has a massive impact on coronary arterydisease detection, treatments, and long-term outcomes.
7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 35 In a large multicenter double-blind randomized trial (LoDoCo2) involving 5,522 patients with clinically stable coronary arterydisease, almost all of them on statin therapy, colchicine, 0.5
tim.hodson Mon, 01/13/2025 - 16:24 A new studyreports persistent disparities in outcomes for people with peripheralarterydisease (PAD) and its more severe form, chronic limb-threatening ischemia (CLTI) in the United States. had lower extremity arterial testing, and 38.7%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content